Neuhaus R W, Hepler R S
Ann Ophthalmol. 1980 Oct;12(10):1159-60.
Pupil dilation from commercially available phenylephrine compounds was studied in a group of 11 subjects. Phenylephrine 10% (aq) did not produce significantly more mydriasis than phenylephrine 2.5% (aq) in the general population (P less than 0.05). This suggests that phenylephrine 2.5% can be used instead of phenylephrine 10% for diagnostic dilation.
在一组11名受试者中研究了市售去氧肾上腺素化合物引起的瞳孔散大情况。在一般人群中,10%(水溶液)的去氧肾上腺素产生的瞳孔散大并不比2.5%(水溶液)的去氧肾上腺素显著更多(P<0.05)。这表明2.5%的去氧肾上腺素可用于替代10%的去氧肾上腺素进行诊断性散瞳。